REDWOOD CITY, Calif., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference at the New York Palace Hotel in New York City.
Threshold's CEO, Barry Selick, Ph.D., will present at 11:35 a.m. Eastern Time on Wednesday, November 12, 2008. The presentation may be accessed through the Company's web site (www.thresholdpharm.com under the Webcasts heading in the Investors & Media section).
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, the Company is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.